Compounds > lysine
Page last updated: 2024-08-17

lysine and Cancer of Prostate

lysine has been researched along with Cancer of Prostate in 130 studies

Research

Studies (130)

TimeframeStudies, this research(%)All Research%
pre-19902 (1.54)18.7374
1990's0 (0.00)18.2507
2000's24 (18.46)29.6817
2010's63 (48.46)24.3611
2020's41 (31.54)2.80

Authors

AuthorsStudies
Currie, GM; Gurney, H; Kim, S; Liu, J; Trifunovic, M1
Abdulkadir, SA; Deaton, RJ; Helou, YB; Kajdacsy-Balla, A; Macias, V; Murphy, AB; Murray, M; Nonn, L; Sverdlov, M; Voisine, C; Wang, H; Zenner, ML1
Bénard, F; Keyes, M; Krauze, A; Oh, J; Raman, S; Rousseau, E; Wilson, D1
Bakht, MK; Beltran, H; Cheon, GJ; Dong, X; Fifield, BA; Grimm, J; Hayward, JJ; Kang, KW; Ku, SY; Mader, L; Meister, D; Pillon, A; Porter, LA; Shahbazi-Raz, F; Skubal, M; Stover, M; Stringer, KF; Tamura, R; Trant, JF; Tronchin, A; Venkadakrishnan, VB; Wang, Y; Xue, H1
Hegarty, J; Parathithasan, N; Perry, E; Sutherland, T; Talwar, A; Taubman, K; Wong, LM1
Chi, H; Ding, Y; Shao, J; Shi, T; Wang, X; Yu, H1
O'Connor, D; Perry, E; Sharma, S; Sutherland, TR; Talwar, A; Taubman, K; Wong, LM1
Beloglazkina, EK; Ber, AP; Dashkova, NS; Evteev, SA; Ivanenkov, YA; Machulkin, AE; Majouga, AG; Nimenko, EA; Petrov, SA; Shafikov, RR; Skvortsov, DA; Uspenskaya, AA; Zyk, NY1
Li, C; Lu, Y1
Bassett, J; Choyke, P; Cox, C; Lin, K; Lindenberg, L; Mauguen, A; Mena, E; Patel, T; Rowe, SP; Techasith, T; Thomsen, B; Torrey, R; Ulaner, GA; Yoshida, J1
Beebe, DJ; Carlson, KN; Gilsdorf, CS; Haffner, MC; Heninger, E; Jarrard, DF; Kircher, MR; Krueger, TEG; Lang, JM; McNeel, DG; Rodems, TS; Singh, A; Stahlfeld, CN1
Azuma, H; Burton, F; Carducci, MA; Chakraborty, G; Chen, YH; Davicioni, E; Frank, D; Hirani, R; Kantoff, PW; Lee, GM; Liu, G; Mazzu, YZ; Nandakumar, S; Rajanala, SH; Stopsack, KH; Sweeney, CJ; Wang, XV; Yoshikawa, Y1
Cheng, K; Fetse, J; Guo, Y; Hasan, MR; Jain, A; Lin, CY; Nakhjiri, M; Patel, P; Zhao, Z1
Abikhzer, G; Bahoric, B; Chaussé, G; Ebrahim, A; Maliha, PG; Niazi, T; Nolet, B; Probst, S1
Papke, DJ; Shah, HJ; Spinali, KL1
Gorin, MA; Pomper, MG; Rowe, SP; Solnes, LB; Voter, AF; Werner, RA; Zukotynski, KA1
Henry, C; Scherer, P; Woodruff, R1
Cao, Y; Fan, Z; He, Z; Li, Y; Lin, Z; Ma, L; Wei, X; Wu, C; Xu, H; Yan, L; Yang, P; Yang, Y1
Buck, AK; Bundschuh, L; Bundschuh, RA; Eisenberger, MA; Essler, M; Gorin, MA; Habacha, B; Higuchi, T; Kosmala, A; Lapa, C; Lodge, MA; Lütje, S; Markowski, MC; Pienta, KJ; Pomper, MG; Rowe, SP; Werner, RA1
Chu, Y; Duan, X; Sui, Y; Yang, X; Zhang, J1
Baracaldo-Lancheros, LF; Dykhuizen, EC; Maschinot, CA; McQuade, AJ; Ordonez-Rubiano, SC; Smith, BC; Sood, S; Strohmier, BP; Wang, S1
Balk, SP; Besschetnova, A; Cai, C; Evans, J; Gao, S; Gao, Y; Han, D; Han, W; Labaf, M; Li, M; Liu, M; Macoska, JA; Muriph, RE; Patalano, S; Siegfried, KR; Venkataramani, K; Wang, Z1
Chen, X; Chen, Y; He, C; Jiang, Y; Rocha, S; Sun, J; Wang, M; Xu, Q; Ye, H1
Gu, R; Janknecht, R; Kim, TD; Oh, S; Shin, S; Song, H; Sui, Y1
Chen, H; Chen, ZS; Feng, NH; Fu, DJ; Hu, LH; Jiang, Y; Li, KJ; Li, Y; Liu, FP; Liu, J; Wang, C; Wang, T; Wang, Y; Xie, T; Yu, YZ; Zeng, XZ; Zhao, SC; Zhu, S1
Buncic, G; Cullinane, C; Donnelly, PS; Haskali, MB; Hicks, RJ; McInnes, LE; Roselt, PD; Van Zuylekom, JK; Waldeck, K; Zia, NA1
Archer, S; Bauman, G; Berlin, A; Boylan, C; Chung, HT; Chung, P; Emmett, L; Helou, J; Kapoor, A; Liu, W; Loblaw, A; Lock, M; Metser, U; Morton, G; Pond, GR; Rachinsky, I; Sexton, T; Wolfson, R; Zukotynski, K1
Bracken, B; Kasper, S; Wong, RM; Wu, T1
Chu, JW; Im, H; Kim, H; Lee, JM; Park, IG; Park, SC; Song, H1
Liu, Y; Xu, B1
Cho, SY; Jadvar, H; Kim, CK; Potvin, K; Winquist, E; Zukotynski, KA1
Cai, Y; Chen, L; Chen, Y; Chen, Z; Feng, Y; Fu, Y; Huang, H; Huang, Y; Liu, R; Zhang, Y1
Bodar, YJL; Dahele, M; Hoekstra, OS; Jansen, BHE; Keizer, B; Meijer, D; Nieuwenhuijzen, JA; Oprea-Lager, DE; Srbljin, S; van der Zant, FM; Vellekoop, AE; Vis, AN; Wondergem, M1
Booth, R; Ng, M; Perry, E; Sutherland, TR; Talwar, A; Taubman, K; Wong, LM1
Basuli, F; Butcher, D; Choyke, PL; Edmondson, E; Jagoda, EM; Jansson, KH; Kelly, K; Lin, FI; Opina, ACL; Riba, M; Roy, J; Ton, AT; White, ME; Wong, K; Zhang, X1
Bazylianska, V; Brunzelle, JS; Chowdhury, DD; Edwards, BFP; Heath, EI; Hüttemann, M; Kalpage, HA; Kim, K; Lee, I; Mahapatra, G; Marcus, K; Morse, PT; Podgorski, I; Polin, L; Subedi, P; Turner, AA; Vaishnav, A; Wan, J1
Falegan, OS; Hyndman, ME; Jarvi, K; Vogel, HJ1
Albino, D; Cacciatore, A; Carbone, GM; Catapano, CV; Cavalli, A; Chiorino, G; Civenni, G; Curti, L; Kokanovic, A; Kunderfranco, P; Mapelli, SN; Merulla, J; Mitra, A; Rinaldi, A; Sandrini, G; Sgrignani, J; Shinde, D; Zoma, M1
Lu, L; Ma, D; Xi, Z; Yang, C; Yang, X1
Keam, SJ1
Carter, DM; Gohlke, U; Heinemann, U; Nazaré, M; Neuenschwander, M; Przygodda, J; Specker, E; von Kries, JP1
Gorin, MA; Pienta, KJ; Pomper, MG; Rowe, SP1
Ito, K; Koike, H; Matsui, H; Miyazawa, Y; Nomura, M; Sekine, Y; Shibata, Y; Suzuki, K; Syuto, T1
Bergh, A; Hamidi, A; Heldin, CH; Itoh, S; Landström, M; Marcusson, A; Song, J; Thakur, N1
Allaf, ME; Gorin, MA; Marashdeh, W; Pienta, KJ; Pomper, MG; Ross, AE; Rowe, SP1
Chu, LC; Gorin, MA; Macura, KJ; Pienta, KJ; Pomper, MG; Ross, AE; Rowe, SP1
Knol, RJJ; Peper, JGK; Srbljin, S; van der Zant, FM; Wondergem, M1
Cornelis, FH; Durack, JC; Morris, MJ; Scher, HI; Solomon, SB1
Broos, WAM; Knol, RJJ; Kocken, M; van der Zant, FM; Wondergem, M1
Knol, RJJ; van der Zant, FM; Vlottes, PW; Wondergem, M1
Coetzee, GA; Farnham, PJ; Guo, Y; Hazelett, DJ; Perez, AA; Rhie, SK1
Chun, S; Chung, HJ; Jeong, BH; Kim, HK; Kwon, YD; La, MT; Lee, SH; Lee, SJ; Oh, JM1
Abikhzer, G; Chaussé, G; Laufer, J; Probst, S1
Escudero-Castellanos, A; Ferro-Flores, G; Isaac-Olivé, K; Luna-Gutiérrez, M; Morales-Ávila, E; Ocampo-García, B; Santos-Cuevas, C1
Gomez, E; Gorin, MA; Pienta, KJ; Pomper, MG; Rowe, SP; Tran, PT1
Knol, RJJ; Rafimanesh-Sadr, L; van der Zant, FM; Wondergem, M1
Boellaard, R; Cysouw, MCF; Hendrikse, NH; Hoekstra, OS; Jansen, BHE; Kramer, GM; Oprea-Lager, DE; Schuit, RC; Schwarte, LA; van den Eertwegh, AJM; van Moorselaar, RJA; Vis, AN; Voortman, J; Windhorst, AD; Yaqub, M1
Endepols, H; Krapf, P; Morgenroth, A; Mottaghy, FM; Muñoz Vásquez, S; Neumaier, B; Richarz, R; Zischler, J; Zlatopolskiy, BD1
Broos, WAM; Knol, RJJ; Srbljin, S; van der Zant, FM; Wondergem, M1
Bosco, A; Dhiantravan, N; Hovey, E; Wegner, EA1
Broos, WAM; Knol, RJJ; Meijer, D; van der Zant, FM; Wondergem, M1
Wang, CM; Yang, WH1
Babich, JW; Eckelman, WC; Hillier, SM; Joyal, JL; Lu, G; Maresca, KP; Marquis, JC; Merkin, RD; Zimmerman, CN1
Carver, BS; Chen, Y; Chi, P; Gao, D; Iaquinta, PJ; Rockowitz, S; Sawyers, CL; Scher, HI; Shamu, T; Shukla, S; Sirota, I; Wongvipat, J; Zheng, D1
Chaudhary, J; Glymph, S; Knowell, AE; Morton, DJ; Patel, D; Sharma, P1
Baker, MR; Banerjee, T; Barish, GD; Chakravarti, D; Kim, JY; Luo, Q; Parker, JB; Radhakrishnan, I; Vinckevicius, A; Wei, JJ1
Gudey, SK; Heldin, CH; Landström, M; Sundar, R1
Antonarakis, ES; Bhatnagar, A; Chen, Y; Cho, SY; Dannals, RF; Eisenberger, MA; Fan, H; Mease, RC; Mena, E; Nidal, R; Plyku, D; Pomper, MG; Rowe, SP; Sgouros, G; Szabo, Z; Vranesic, M1
Bracken, B; Ho, SM; Mallick, P; Pinney, SM; Wu, T; Yang, S1
Dietlein, F; Dietlein, M; Drzezga, A; Fischer, T; Kobe, C; Krapf, P; Kuhnert, G; Neubauer, S; Neumaier, B; Richarz, R; Schmidt, M; Schomäcker, K; Stockter, S; Zlatopolskiy, BD1
Chen, Y; Foss, CA; Hobbs, R; Kiess, AP; Mease, RC; Minn, I; Pomper, MG; Pullambhatla, M; Sgouros, G; Shen, CJ1
Chen, J; Cheong, A; Ho, SM; Hu, WY; Lam, HM; Leung, YK; Medvedovic, M; Prins, GS; Shi, GB; Zhang, X; Zhu, X1
Alam, K; Ali, A; Habib, S; Khan, F; Mir, AR1
Abbas, A; Al-Mulla, F; Georgel, PT; Hall, JA; Ho, E; Hsu, A; Patterson, WL1
Aoyagi, T; Ebara, M; Okada, T; Uto, K1
Agnarsson, BA; Aittomäki, K; Andrulis, IL; Anton-Culver, H; Antoniou, AC; Bandera, EV; Banerjee, S; Barile, M; Barrowdale, D; Beckman, MW; Beeghly-Fadiel, A; Benitez, J; Berchuck, A; Bjorge, L; Blomqvist, C; Bogdanova, NV; Bojesen, SE; Bolla, MK; Borg, A; Borresen-Dale, AL; Brauch, H; Brenner, H; Broeks, A; Bruinsma, F; Brunet, J; Brüning, T; Burwinkel, B; Butterbach, K; Butzow, R; Buys, SS; Cai, H; Campbell, IG; Cannioto, R; Castillo, D; Chan, SB; Chang-Claude, J; Chenevix-Trench, G; Claes, KB; Collavoli, A; Cook, LS; Couch, FJ; Cox, A; Cramer, D; Cross, SS; Cunningham, JM; Czene, K; Daly, MB; Damiola, F; Darabi, H; Dennis, J; Devilee, P; Diez, O; Ding, YC; Doherty, JA; Domchek, SM; Dorfling, CM; Dörk, T; Dunning, AM; Easton, DF; Eccles, DM; Ellis, S; Eunjung, L; Fasching, PA; Feng, B; Figueroa, J; Flesch-Janys, D; Fletcher, O; Flyger, H; Foretova, L; Fostira, F; Friedman, E; Frost, D; Ganz, PA; Gao, YT; Garber, J; García-Closas, M; Gayther, S; Gerdes, AM; Giles, GG; Glasspool, R; Godwin, AK; Goldberg, MS; Goldgar, DE; González-Neira, A; Goode, EL; Goodman, MT; Greene, MH; Gronwald, J; Guénel, P; Hahnen, E; Haiman, CA; Hall, P; Hallberg, E; Hamann, U; Hansen, TV; Hart, SN; Healey, S; Heitz, F; Henderson, BE; Henriksson, K; Hildebrant, MA; Hogdall, C; Hogdall, E; Hogervorst, FB; Hopper, JL; Hosono, S; Hoya, Mde L; Hulick, PJ; Imyanitov, EN; Isaacs, C; Jakubowska, A; James, PA; Janavicius, R; Jensen, A; John, EM; Johnson, N; Jones, M; Kabisch, M; Karlan, BY; Khan, S; Kiemeney, LA; Kjaer, SK; Knight, JA; Konstantopoulou, I; Koppert, LB; Kosma, VM; Kristensen, V; Kupryjanczyk, J; Kwong, A; Laitman, Y; Lambrechts, D; Lazaro, C; Le, N; Lester, J; Levine, D; Li, J; Liang, D; Lindblom, A; Loud, JT; Lu, KH; Lubinski, J; Maerken, TV; Mai, PL; Mannermaa, A; Manoukian, S; Margolin, S; Marme, F; Massuger, LF; Matsuo, K; Maugard, C; Mazoyer, S; McGuffog, L; McNeish, I; Meeks, HD; Meindl, A; Menon, U; Michailidou, K; Milne, RL; Modugno, F; Moes-Sosnowska, J; Montagna, M; Monteiro, AN; Moysich, KB; Narod, S; Nathanson, KL; Ness, R; Neuhausen, SL; Nevanlinna, H; Neven, P; Nussbaum, RL; Offit, K; Öfverholm, A; Olah, E; Oliani, C; Olopade, OI; Olson, JE; Olson, SH; Osorio, A; Ouweland, AM; Park, SK; Pasini, BJ; Pearce, L; Pedersen, IS; Peissel, B; Peixoto, A; Pejovic, T; Pelttari, LM; Peterlongo, P; Pharoah, PD; Phelan, CM; Piedmonte, M; Poole, EM; Pylkäs, K; Radice, P; Ramus, SJ; Rantala, J; Rappaport-Feurhauser, C; Rennert, G; Riboli, E; Risch, H; Robson, M; Rossing, MA; Rudolph, A; Salvesen, HB; Sawyer, EJ; Schildkraut, J; Schmidt, MK; Schoemaker, MJ; Segura, PP; Senter, L; Shah, M; Shimelis, H; Siddiquil, N; Sieh, W; Simard, J; Singer, CF; Sinilnikova, OM; Slager, S; Song, H; Soucy, P; Southey, MC; Spurdle, AB; Stoppa-Lyonnet, D; Swerdlow, A; Teixeira, MR; Teo, SH; Terry, KL; Terry, MB; Tesoriero, A; Thomassen, M; Thompson, PJ; Tihomirova, L; Tischkowitz, M; Tollenaar, RA; Tomlinson, I; Torres, D; Truong, T; Tucker, K; Tung, N; Tworoger, SS; van Rensburg, EJ; Varon-Mateeva, R; Viel, A; Wang, Q; Wappenschmidt, B; Weitzel, JN; Wentzensen, N; Whittermore, AS; Winqvist, R; Woo, YL; Wu, A; Yoon, SY; Zheng, W1
Gorin, MA; Javadi, MS; Leal, JP; Mana-Ay, M; Pienta, KJ; Pomper, MG; Ross, AE; Rowe, SP; Szabo, Z1
Hou, L; Li, M; Li, Q; Yu, Y; Zhang, D1
Cang, S; Chiao, JW; Liu, D; Ma, Y; Xu, X1
Antonarakis, ES; Blackford, AL; Carducci, M; Chen, Y; Cho, SY; Dannals, RF; Eisenberger, M; Fan, H; Macura, KJ; Mease, RC; Mena, E; Nadal, R; Pomper, MG; Rowe, SP; Szabo, Z1
Andreas, D; Gorin, MA; Lotan, TL; Pienta, KJ; Pomper, MG; Ross, AE; Rowe, SP; Szabo, Z; Tosoian, JJ1
Adunyah, SE; Ballard, BR; Chen, Z; Izban, MG; Li, B; Liu, S; Lu, W; Matusik, RJ; Sathyanarayana, SA; Xie, Y1
Chaudhary, J; Hunt, A; Joshi, J; Knowell, AE; Morton, DJ; Patel, D1
Chakravarti, D; Chen, JR; Chen, P; Deng, P; DePinho, RA; Dey, P; Lan, Z; Li, J; Liang, X; Liao, W; Lu, X; Navone, NM; Shah, S; Shang, X; Spring, DJ; Tang, M; Troncoso, P; Wang, G; Wang, YA; Zhang, J; Zhao, D1
Drzezga, A; Gorin, MA; Pomper, MG; Rowe, SP; Salas Fragomeni, RA1
Ateeq, B; Brenner, JC; Cao, Q; Cao, X; Chinnaiyan, AM; Han, B; Jing, X; Kim, JH; Kumar-Sinha, C; Laxman, B; Lonigro, RJ; Maher, CA; Mani, RS; Palanisamy, N; Ramnarayanan, K; Shankar, S; Tan, P; Varambally, S; Wang, X; Yu, J1
Gioeli, D; Jääskeläinen, T; Kaikkonen, S; Karvonen, U; Makkonen, H; Palvimo, JJ; Paschal, BM; Rytinki, MM1
Akslen, LA; Goldfinger, N; Halvorsen, OJ; Haukaas, SA; Jonassen, I; Kalland, KH; Ke, XS; Li, WC; Lin, B; Oyan, AM; Petersen, K; Qu, Y; Rostad, K; Rotter, V1
Fink, A; Makovitzki, A; Shai, Y1
Allis, CD; Cook, RG; Frierson, HF; Fujita, M; Fukusato, T; Iizuka, M; Mizzen, CA; Smith, MM; Takahashi, Y1
Arthur, K; Diamond, J; Hamilton, PW; Maxwell, P; McKelvey-Martin, VJ; McKenna, DJ; Watson, JA1
Niwa, T; Shimazu, T; Takeshima, H; Ushijima, T; Yamashita, S1
Babich, JW; Barrett, JA; Eckelman, WC; Femia, FJ; Foss, CA; Hillier, SM; Joyal, JL; Maresca, KP; Marquis, JC; Nguyen, N; Pomper, MG; Zimmerman, CN1
Beisenherz-Huss, C; Buettner, R; Friedrichs, N; Greschik, H; Günther, T; Hoffmeyer, K; Imhof, A; Ji, S; Kahl, P; Kirfel, J; Kunowska, N; Metzger, E; Müller, JM; Patel, D; Schüle, R1
Albertini, V; Cangemi, R; Carbone, GM; Catapano, CV; Chiorino, G; Kunderfranco, P; Malek, A; Mello-Grand, M; Mensah, A; Pellini, S1
Gil, J; Li, S; Mujtaba, S; Muñoz-Cabello, AM; Raguz, S; Walsh, MJ; Yap, KL; Zeng, L; Zhou, MM1
Armstrong, K; Gaughan, L; McCracken, SR; McEwan, IJ; Pestell, RG; Robson, CN; Shaheen, F; Stockley, J; Treumann, A; Wang, C; Wang, N; Watt, K1
Choi, BH; Choi, EK; Jeong, SY; Oh, ET; Park, HJ; Park, MT; Ro, S1
Chen, X; Radany, EH; Wong, JY; Wong, P1
Chu, Y; Guan, KL; Huang, Y; Lei, QY; Li, D; Li, Z; Lin, R; Liu, Y; Lv, L; Wang, G; Xiong, Y; Xu, Y; Zha, Z; Zhang, H; Zhao, D1
Brans, L; Däpp, S; García Garayoa, E; Maes, V; Müller, C; Schibli, R; Tourwé, DA1
Byun, Y; Chen, Y; Foss, CA; Mease, RC; Nimmagadda, S; Pomper, MG; Pullambhatla, M; Senthamizhchelvan, S; Sgouros, G1
Ames, RS; Li, H; Xie, W1
Cheng, WP; Ding, C; Gu, J; Guo, J; O'Driscoll, C; Qu, X; Yang, Z1
Bethel, C; De Marzo, AM; Gurel, B; Hicks, J; Iwata, T; Pellakuru, LG; Schultz, D; Yegnasubramanian, S1
Chin, YR; Finley, LW; Fukushima, H; Gao, D; Gygi, SP; Haigis, MC; Inuzuka, H; Lau, AW; Nakayama, K; Pandolfi, PP; Shaik, S; Teruya-Feldstein, J; Toker, A; Wan, L; Wang, Z; Wei, W; Yang, W; Zhai, B1
Alapinar, C; Debelec-Butuner, B; Erbaykent-Tepedelen, B; Gonen-Korkmaz, C; Hamid, SM; Korkmaz, KS; Varisli, L1
Futscher, BW; Severson, PL; Tokar, EJ; Vrba, L; Waalkes, MP1
Bieberich, CJ; Gosc, EB; Padmanabhan, A1
Banerjee, SR; Byun, Y; Chen, Y; Mease, RC; Pomper, MG; Pullambhatla, M; Rojas, C; Slusher, BS; Stathis, M1
Himmelreich, U; Khadra, M; Lean, C; McCredie, S; Mountford, C; Russell, P; Swindle, P1
Papo, N; Shai, Y1
KRISHNA, G1
Fu, M; Gioeli, D; Hessien, M; Pestell, RG; Rao, M; Wang, C; Weber, MJ; Wu, K; Yeung, YG; Zhang, X1
Abate-Shen, C; Chuikov, S; Farnham, P; Karachentsev, D; Kirmizis, A; Kuzmichev, A; Margueron, R; Nishioka, K; Preissner, TS; Reinberg, D; Sarma, K; Steward, R; Vaquero, A1
Degani, H; Eshhar, Z; Kalchenko, V; Makovitzki, A; Papo, N; Seger, D; Shai, Y1
Jiang, X; Wang, Y1
Bomshteyn, A; Hao, M; Katdare, M; Kisilis, E; Oktem, O; Rathnam, P; Saxena, BB; Zhu, L1
Avantaggiati, ML; Fu, M; Gu, W; Jiao, X; Liu, M; Pattabiraman, N; Pestell, RG; Pestell, TG; Powell, MJ; Quong, AA; Sauve, AA; Wang, C; Wang, F; Wu, X; Yang, T; Zhang, X1
Azzouzi, AR; Cancel-Tassin, G; Cormier, L; Cussenot, O; Fournier, G; Mangin, P; Nicolaiew, N; Valeri, A1
Ivanov, V; Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW1
Chen, CD; Han, G; Lin, H; Xiang, Y; Xu, L; Zhu, Z1
Gawdi, G; Gonzalez-Gronow, M; Kaczowka, S; Pizzo, SV1
Chen, AP; Chen, CD; Han, G; Lin, H; Ma, Y; Peng, Z; Xiang, Y; Xu, B; Ye, X; Yu, Y; Zhu, Z1
Baek, SH; Choi, HJ; Chung, CH; Kim, JH; Kim, KI; Kim, MH; Kim, SI; Lee, JM; Lee, JS; Nam, HJ; Yang, JW1
Ahmed, S; Boumber, Y; Charo, C; Cheng, AS; Furukawa, K; Gold, DL; Huang, TH; Issa, JP; Kondo, Y; Kwabi-Addo, B; Sekido, Y; Shen, L; Urano, T; Yamochi, T1
Burns, MR; Cai, F; Carlson, CL; Devens, BH; O'Day, CL; Vanderwerf, SM; Webb, HK; Weeks, RS1
Chang, C; Chang, HC; Fujimoto, N; Kang, HY; Miyamoto, H; Nishimura, K; Rahman, M; Takatera, H; Yeh, S1
Bürgi, W; Schärer, HU1

Reviews

4 review(s) available for lysine and Cancer of Prostate

ArticleYear
Piflufolastat F 18: Diagnostic First Approval.
    Molecular diagnosis & therapy, 2021, Volume: 25, Issue:5

    Topics: Gallium Radioisotopes; Humans; Lysine; Male; Positron-Emission Tomography; Prostatic Neoplasms

2021
Clinical Experience with
    PET clinics, 2017, Volume: 12, Issue:2

    Topics: Antigens, Surface; Cysteine; Drug Evaluation, Preclinical; Fluorine Radioisotopes; Glutamate Carboxypeptidase II; Glutarates; Humans; Lysine; Male; Organophosphonates; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Urea

2017
Steps toward understanding the inheritance of repressive methyl-lysine marks in histones.
    Cold Spring Harbor symposia on quantitative biology, 2004, Volume: 69

    Topics: Amino Acid Sequence; Animals; Drosophila; Drosophila Proteins; Epigenesis, Genetic; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Male; Methylation; Mice; Nuclear Proteins; Polycomb Repressive Complex 2; Prostatic Neoplasms; Protein Methyltransferases; Repressor Proteins; Sequence Homology, Amino Acid

2004
Dipeptidyl peptidase IV (DPP IV/CD26) is a cell-surface plasminogen receptor.
    Frontiers in bioscience : a journal and virtual library, 2008, Jan-01, Volume: 13

    Topics: Adenosine Deaminase; Binding Sites; Cell Line, Tumor; Cytosol; Dipeptidyl Peptidase 4; Humans; Hydrogen-Ion Concentration; Ligands; Lysine; Male; Neoplasm Invasiveness; Plasminogen; Prostatic Neoplasms; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers

2008

Trials

4 trial(s) available for lysine and Cancer of Prostate

ArticleYear
Patterns of Prostate Cancer Recurrence After Brachytherapy Determined by Prostate-Specific Membrane Antigen-Positron Emission Tomography and Computed Tomography Imaging.
    International journal of radiation oncology, biology, physics, 2022, 04-01, Volume: 112, Issue:5

    Topics: Brachytherapy; Humans; Lysine; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Tomography, X-Ray Computed; Urea

2022
    Radiology, 2022, Volume: 305, Issue:2

    Topics: Aged; Humans; Lysine; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostatic Neoplasms; Pyridines; Tomography, X-Ray Computed; Urea

2022
Effects of Fasting on
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018, Volume: 59, Issue:7

    Topics: Aged; Aged, 80 and over; Biological Transport; Fasting; Humans; Lysine; Male; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Urea

2018
PSMA-Based [(18)F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer.
    Molecular imaging and biology, 2016, Volume: 18, Issue:3

    Topics: Aged; Aged, 80 and over; Demography; Humans; Lysine; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Regression Analysis; Urea; Whole Body Imaging

2016

Other Studies

122 other study(ies) available for lysine and Cancer of Prostate

ArticleYear
    Journal of nuclear medicine technology, 2022, Volume: 50, Issue:3

    Topics: Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Ligands; Lysine; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Urea

2022
Advanced glycation end-products (AGEs) are lower in prostate tumor tissue and inversely related to proportion of West African ancestry.
    The Prostate, 2022, Volume: 82, Issue:3

    Topics: Age Factors; Black or African American; Correlation of Data; Glycated Hemoglobin; Glycation End Products, Advanced; Humans; Immunohistochemistry; Lysine; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Hyperplasia; Prostatic Neoplasms; Warburg Effect, Oncologic; White People

2022
Identification of alternative protein targets of glutamate-ureido-lysine associated with PSMA tracer uptake in prostate cancer cells.
    Proceedings of the National Academy of Sciences of the United States of America, 2022, 01-25, Volume: 119, Issue:4

    Topics: Animals; Antigens, Surface; Binding Sites; Cell Cycle Proteins; Disease Models, Animal; Disease Progression; Fluorescent Antibody Technique; Fluorescent Dyes; Gene Expression; Glutamate Carboxypeptidase II; Glutamates; Humans; Immunohistochemistry; Lysine; Male; Mice; Models, Molecular; Molecular Conformation; Molecular Imaging; Molecular Probes; Prostatic Neoplasms; Protein Binding; Receptors, Kainic Acid; Structure-Activity Relationship; Urea

2022
Combination of MRI prostate and 18F-DCFPyl PSMA PET/CT detects all clinically significant prostate cancers in treatment-naive patients: An international multicentre retrospective study.
    Journal of medical imaging and radiation oncology, 2022, Volume: 66, Issue:7

    Topics: Humans; Lysine; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms; Retrospective Studies; Urea

2022
Leukemia inhibitory factor receptor homodimerization mediated by acetylation of extracellular lysine promotes prostate cancer progression through the PDPK1/AKT/GCN5 axis.
    Clinical and translational medicine, 2022, Volume: 12, Issue:2

    Topics: 3-Phosphoinositide-Dependent Protein Kinases; Acetylation; Animals; Disease Progression; Lysine; Male; Mice; Prostatic Neoplasms; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Receptors, OSM-LIF

2022
Non-prostate cancer tumours: incidence on
    European journal of nuclear medicine and molecular imaging, 2022, Volume: 49, Issue:9

    Topics: Carcinoma, Renal Cell; Humans; Incidence; Kidney Neoplasms; Lysine; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Urea

2022
Synthesis and initial in vitro evaluation of PSMA-targeting ligands with a modified aromatic moiety at the lysine ε-nitrogen atom.
    Bioorganic & medicinal chemistry letters, 2022, 09-01, Volume: 71

    Topics: Antigens, Surface; Cell Line, Tumor; Glutamate Carboxypeptidase II; Humans; Ligands; Lysine; Male; Nitrogen; Prostatic Neoplasms

2022
Incidental Findings of Coexisting Metastatic Pancreatic Cancer in Patients With Prostate Cancer on 18 F-Prostate-Specific Membrane Antigen PET/CT.
    Clinical nuclear medicine, 2022, Dec-01, Volume: 47, Issue:12

    Topics: Aged; Gallium Radioisotopes; Humans; Incidental Findings; Lysine; Male; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies; Urea

2022
Reversible epigenetic alterations regulate class I HLA loss in prostate cancer.
    Communications biology, 2022, 09-01, Volume: 5, Issue:1

    Topics: CD8-Positive T-Lymphocytes; Chromatin; DNA Methylation; Epigenesis, Genetic; Epigenomics; Histocompatibility Antigens Class I; Histone Deacetylases; HLA Antigens; Humans; Lysine; Male; Prostatic Neoplasms

2022
Increased MYBL2 expression in aggressive hormone-sensitive prostate cancer.
    Molecular oncology, 2022, Volume: 16, Issue:22

    Topics: Androgen Antagonists; Androgens; Cell Cycle Proteins; Docetaxel; Histone Demethylases; Humans; Lysine; Male; Minor Histocompatibility Antigens; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Taxoids; Trans-Activators

2022
Development of amino acid-modified biodegradable lipid nanoparticles for siRNA delivery.
    Acta biomaterialia, 2022, Volume: 154

    Topics: Amino Acids; Animals; Humans; Lipids; Lysine; Male; Mice; Nanoparticles; Pancreatic Neoplasms; Prostatic Neoplasms; RNA, Small Interfering

2022
Comparing digital to analog prostate-specific membrane antigen-targeted piflufolastat 18 F PET/CT in prostate cancer patients in early biochemical failure.
    Nuclear medicine communications, 2023, 03-01, Volume: 44, Issue:3

    Topics: Gallium Radioisotopes; Humans; Lysine; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies

2023
Hepatic Small Vessel Neoplasm Mimics Prostate Cancer on 18 F-DCFPyl PET/CT.
    Clinical nuclear medicine, 2023, Apr-01, Volume: 48, Issue:4

    Topics: Humans; Lysine; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Urea

2023
Image acquisition and interpretation of 18F-DCFPyL (piflufolastat F 18) PET/CT: How we do it.
    The Canadian journal of urology, 2023, Volume: 30, Issue:1

    Topics: Humans; Lysine; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatic Neoplasms

2023
Peritoneal Carcinomatosis of Prostate Cancer with PSMA-targeted
    Radiology. Imaging cancer, 2023, Volume: 5, Issue:2

    Topics: Humans; Lysine; Male; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms

2023
Discovery of a novel 1H-pyrazole- [3,4-b] pyridine-based lysine demethylase 5B inhibitor with potential anti-prostate cancer activity that perturbs the phosphoinositide 3-kinase/AKT pathway.
    European journal of medicinal chemistry, 2023, May-05, Volume: 251

    Topics: Cell Line, Tumor; Humans; Jumonji Domain-Containing Histone Demethylases; Lysine; Male; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Pyrazoles; Pyridines

2023
Test-retest repeatability of organ uptake on PSMA-targeted
    The Prostate, 2023, Volume: 83, Issue:12

    Topics: Humans; Lysine; Male; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostatic Neoplasms; Urea

2023
Synthesis and characterization of a novel
    Bioorganic & medicinal chemistry letters, 2023, Jul-15, Volume: 91

    Topics: Animals; Antigens, Surface; Cell Line, Tumor; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Ligands; Lysine; Male; Mice; Positron-Emission Tomography; Prostatic Neoplasms; Tissue Distribution; Urea

2023
Rational Design and Development of Selective BRD7 Bromodomain Inhibitors and Their Activity in Prostate Cancer.
    Journal of medicinal chemistry, 2023, 08-24, Volume: 66, Issue:16

    Topics: Chromosomal Proteins, Non-Histone; Humans; Ligands; Lysine; Male; Prostatic Neoplasms; Transcription Factors

2023
Demethylation of EHMT1/GLP Protein Reprograms Its Transcriptional Activity and Promotes Prostate Cancer Progression.
    Cancer research communications, 2023, Volume: 3, Issue:8

    Topics: Chromatin; Demethylation; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Male; Neoplastic Processes; Prostatic Hyperplasia; Prostatic Neoplasms

2023
Comprehensive analysis of the lysine succinylome in fish oil-treated prostate cancer cells.
    Life science alliance, 2023, Volume: 6, Issue:11

    Topics: Fish Oils; Humans; Lysine; Male; Mitochondria; Prostate; Prostatic Neoplasms

2023
SET7/9-mediated methylation affects oncogenic functions of histone demethylase JMJD2A.
    JCI insight, 2023, Oct-23, Volume: 8, Issue:20

    Topics: Carcinogenesis; Cell Transformation, Neoplastic; Histone Demethylases; Humans; Jumonji Domain-Containing Histone Demethylases; Lysine; Male; Matrix Metalloproteinase 1; Methylation; Prostatic Neoplasms

2023
SETD4 inhibits prostate cancer development by promoting H3K27me3-mediated NUPR1 transcriptional repression and cell cycle arrest.
    Cancer letters, 2023, Nov-28, Volume: 579

    Topics: Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Histones; Humans; Lysine; Male; Methyltransferases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt

2023
A Bivalent Inhibitor of Prostate Specific Membrane Antigen Radiolabeled with Copper-64 with High Tumor Uptake and Retention.
    Angewandte Chemie (International ed. in English), 2019, 10-14, Volume: 58, Issue:42

    Topics: Animals; Antigens, Surface; Binding Sites; Cell Line, Tumor; Copper Radioisotopes; Dipeptides; Glutamate Carboxypeptidase II; Glutamates; Humans; Lysine; Male; Mice; Prostatic Neoplasms; Protein Binding; Radiopharmaceuticals; Theranostic Nanomedicine; Tissue Distribution; Urea

2019
A Prospective Study of 18F-DCFPyL PSMA PET/CT Restaging in Recurrent Prostate Cancer following Primary External Beam Radiotherapy or Brachytherapy.
    International journal of radiation oncology, biology, physics, 2020, 03-01, Volume: 106, Issue:3

    Topics: Aged; Aged, 80 and over; Antigens, Surface; Fluorine Radioisotopes; Glutamate Carboxypeptidase II; Humans; Kallikreins; Lysine; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Urea

2020
Identification of Differential Patterns of Oxidative Biomarkers in Prostate Cancer Progression.
    Clinical genitourinary cancer, 2020, Volume: 18, Issue:2

    Topics: Aged; Aged, 80 and over; Biomarkers; Disease Progression; F2-Isoprostanes; Follow-Up Studies; Humans; Kallikreins; Lysine; Male; Middle Aged; Oxidative Stress; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Risk Assessment; Watchful Waiting

2020
Isoform-Specific Lysine Methylation of RORα2 by SETD7 Is Required for Association of the TIP60 Coactivator Complex in Prostate Cancer Progression.
    International journal of molecular sciences, 2020, Feb-27, Volume: 21, Issue:5

    Topics: Animals; Cell Proliferation; Chromatin Immunoprecipitation; Chromatography, Liquid; Disease Progression; Gene Expression Regulation, Neoplastic; Histone-Lysine N-Methyltransferase; Humans; Lysine; Lysine Acetyltransferase 5; Male; Methylation; Mice; Mice, Nude; Nuclear Receptor Subfamily 1, Group F, Member 1; Oncogenes; PC-3 Cells; Prostatic Neoplasms; Protein Binding; Protein Domains; Protein Isoforms; Tandem Mass Spectrometry; Trans-Activators

2020
Primary Peripheral Primitive Neuroectodermal Tumor of the Prostate on 18F-DCFPyL PET/CT.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:5

    Topics: Adult; Dysuria; Humans; Lysine; Magnetic Resonance Imaging; Male; Neuroectodermal Tumors, Primitive, Peripheral; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Urea

2020
Prostate Cancer Lymphangitic Pulmonary Carcinomatosis: Appearance on 18F-FDG PET/CT and 18F-DCFPyL PET/CT.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:9

    Topics: Disease Progression; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lysine; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Prostatic Neoplasms; Urea

2020
Acetylation-mediated degradation of HSD17B4 regulates the progression of prostate cancer.
    Aging, 2020, 07-17, Volume: 12, Issue:14

    Topics: Acetylation; Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; CREB-Binding Protein; Disease Progression; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Lysine; Male; Mice; Mice, Knockout; Neoplasm Invasiveness; Peroxisomal Multifunctional Protein-2; Prostatic Neoplasms; Sirtuin 3; Testosterone; Xenograft Model Antitumor Assays

2020
Clinical verification of 18F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer.
    PloS one, 2020, Volume: 15, Issue:10

    Topics: Aged; Humans; Image Processing, Computer-Assisted; Lysine; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Retrospective Studies; Urea

2020
[
    European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:6

    Topics: Fluorine Radioisotopes; Humans; Lysine; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Urea

2021
Monitoring PSMA Responses to ADT in Prostate Cancer Patient-Derived Xenograft Mouse Models Using [
    Molecular imaging and biology, 2021, Volume: 23, Issue:5

    Topics: Androgen Antagonists; Animals; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Disease Models, Animal; Humans; Lysine; Male; Mice; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Urea; Xenograft Model Antitumor Assays

2021
Lysine 53 Acetylation of Cytochrome
    Cells, 2021, 04-03, Volume: 10, Issue:4

    Topics: Acetylation; Animals; Apoptosis; Cardiolipins; Caspase 3; Cell Line, Tumor; Crystallography, X-Ray; Cytochromes c; Electron Transport Complex IV; Humans; Lysine; Male; Mice; Molecular Dynamics Simulation; Mutation; Oxidation-Reduction; Oxygen Consumption; Peroxidase; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Reactive Oxygen Species; Warburg Effect, Oncologic; Xenograft Model Antitumor Assays

2021
Seminal plasma metabolomics reveals lysine and serine dysregulation as unique features distinguishing between prostate cancer tumors of Gleason grades 6 and 7.
    The Prostate, 2021, Volume: 81, Issue:11

    Topics: Aged; Biomarkers, Tumor; Biopsy; Diagnosis, Differential; Humans; Lysine; Magnetic Resonance Spectroscopy; Male; Metabolomics; Middle Aged; Neoplasm Grading; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; ROC Curve; Semen; Serine

2021
EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer.
    Nature communications, 2021, 07-06, Volume: 12, Issue:1

    Topics: Adenocarcinoma; Animals; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Lysine; Male; Mice; Mice, Knockout; Oncogene Proteins; Oncogene Proteins, Fusion; Prostatic Neoplasms; Protein Conformation; Protein Processing, Post-Translational; Sequence Alignment; Serine Endopeptidases; Trans-Activators; Transcription Factors; Transcriptional Regulator ERG

2021
Synthesis of KUE-siRNA Conjugates for Prostate Cancer Cell-Targeted Gene Silencing.
    Chembiochem : a European journal of chemical biology, 2021, 10-01, Volume: 22, Issue:19

    Topics: Antigens, Surface; Gene Silencing; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Lysine; Male; Prostatic Neoplasms; RNA, Small Interfering; Urea

2021
FDA approves a second PSMA targeting agent for PET imaging in men with prostate cancer.
    BJU international, 2021, Volume: 128, Issue:2

    Topics: Gallium Isotopes; Gallium Radioisotopes; Humans; Lysine; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; United States; United States Food and Drug Administration; Urea

2021
Identification of a Novel Benzimidazole Pyrazolone Scaffold That Inhibits KDM4 Lysine Demethylases and Reduces Proliferation of Prostate Cancer Cells.
    SLAS discovery : advancing life sciences R & D, 2017, Volume: 22, Issue:7

    Topics: Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Demethylation; Enzyme Inhibitors; Histone Demethylases; Histones; Humans; Hydroxyquinolines; Jumonji Domain-Containing Histone Demethylases; Lysine; Male; PC-3 Cells; Prostatic Neoplasms; Pyrazolones; Receptors, Androgen; Transcription, Genetic

2017
Prostate Cancer Local Recurrence Detected With Both
    Urology, 2017, Volume: 107

    Topics: Aged; Antigens, Surface; Carboxylic Acids; Cyclobutanes; Fluorine Radioisotopes; Glutamate Carboxypeptidase II; Humans; Lysine; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Urea

2017
Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab.
    Anticancer research, 2017, Volume: 37, Issue:7

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Arginine; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Denosumab; Femur Neck; Fractures, Bone; Humans; Lumbar Vertebrae; Lysine; Male; Middle Aged; Osteoporosis; Prostatic Neoplasms; Retrospective Studies; Tartrate-Resistant Acid Phosphatase

2017
TGF-β promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85α.
    Science signaling, 2017, Jul-04, Volume: 10, Issue:486

    Topics: Animals; Apoptosis; Cell Movement; Cells, Cultured; Class Ia Phosphatidylinositol 3-Kinase; Embryo, Mammalian; Fibroblasts; Humans; Lysine; Male; Mice; Mice, Knockout; Phosphorylation; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Signal Transduction; TNF Receptor-Associated Factor 6; Transforming Growth Factor beta; Ubiquitination

2017
Uptake of the prostate-specific membrane antigen-targeted PET radiotracer 18F-DCFPyL in elastofibroma dorsi.
    Nuclear medicine communications, 2017, Volume: 38, Issue:9

    Topics: Aged; Aged, 80 and over; Antigens, Surface; Biomarkers, Tumor; Computer Simulation; Diagnosis, Differential; Glutamate Carboxypeptidase II; Humans; Image Interpretation, Computer-Assisted; Lysine; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Soft Tissue Neoplasms; Tissue Distribution; Urea

2017
An Unusual Case of Penile Prostate Cancer Uncovered by Multiparametric MRI and PSMA-Targeted 18F-DCFPyL PET/CT.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:10

    Topics: Antigens, Surface; Glutamate Carboxypeptidase II; Humans; Lysine; Magnetic Resonance Imaging; Male; Middle Aged; Penile Neoplasms; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Urea

2017
High 18Fluor-DCFPyL Uptake in Adrenal Adenomas.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:11

    Topics: Adenoma; Adrenal Gland Neoplasms; Aged; Biological Transport; Humans; Lysine; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Urea

2017
Effective Prostate-Specific Membrane Antigen-Based 18F-DCFPyL-Guided Cryoablation of a Single Positive Site in a Patient Believed to Be More Metastatic on 11C-Choline PET/CT.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:12

    Topics: Aged; Antigens, Surface; Carbon Radioisotopes; Choline; Cryosurgery; Glutamate Carboxypeptidase II; Humans; Lysine; Male; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Surgery, Computer-Assisted; Urea

2017
Metastasized 18F-DCFPyL-Negative Prostatic Adenocarcinoma Without Neuroendocrine Differentiation.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:2

    Topics: Adenocarcinoma; Aged; Humans; Lysine; Male; Neoplasm Metastasis; Neurosecretory Systems; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Urea

2018
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops.
    Genome biology, 2018, 10-08, Volume: 19, Issue:1

    Topics: Acetylation; CCCTC-Binding Factor; Cell Line, Tumor; Chromatin; Clustered Regularly Interspaced Short Palindromic Repeats; Enhancer Elements, Genetic; Gene Deletion; Histones; Humans; Lysine; Male; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Risk Factors; Small-Conductance Calcium-Activated Potassium Channels; Up-Regulation

2018
Synthesis and Evaluation of Multifunctional Fluorescent Inhibitors with Synergistic Interaction of Prostate-Specific Membrane Antigen and Hypoxia for Prostate Cancer.
    Bioconjugate chemistry, 2019, 01-16, Volume: 30, Issue:1

    Topics: Animals; Antigens, Surface; Cell Hypoxia; Cell Line, Tumor; Female; Fluorescent Dyes; Glutamate Carboxypeptidase II; Glutamic Acid; Heterografts; Humans; Lysine; Male; Mice; Mice, Inbred BALB C; Prostatic Neoplasms; Tissue Distribution; Urea

2019
Splenic Hemangioma as a Potential Pitfall on PSMA-Targeted 18F-DCFPyL PET/CT.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:3

    Topics: Aged; Antigens, Surface; Glutamate Carboxypeptidase II; Hemangioma; Humans; Lysine; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Splenic Neoplasms; Urea

2019
Synthesis and preclinical evaluation of the 177Lu-DOTA-PSMA(inhibitor)-Lys3-bombesin heterodimer designed as a radiotheranostic probe for prostate cancer.
    Nuclear medicine communications, 2019, Volume: 40, Issue:3

    Topics: Animals; Antigens, Surface; Bombesin; Cell Line, Tumor; Chemistry Techniques, Synthetic; Dimerization; Glutamate Carboxypeptidase II; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Lysine; Male; Mice; Prostatic Neoplasms; Radiochemistry; Radioisotopes; Tissue Distribution; Tomography, Emission-Computed, Single-Photon

2019
Hereditary Spherocytosis Presenting as Diffuse Bone Marrow Activation and Splenomegaly on PSMA-Targeted 18F-DCFPyL PET/CT.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:4

    Topics: Aged; Antigens, Surface; Bone Marrow; Glutamate Carboxypeptidase II; Humans; Lysine; Male; Positron Emission Tomography Computed Tomography; Prostatectomy; Prostatic Neoplasms; Spherocytosis, Hereditary; Splenomegaly; Urea

2019
Effect of forced diuresis during 18F-DCFPyL PET/CT in patients with prostate cancer: activity in ureters, kidneys and bladder and occurrence of halo artefacts around kidneys and bladder.
    Nuclear medicine communications, 2019, Volume: 40, Issue:6

    Topics: Aged; Aged, 80 and over; Artifacts; Cohort Studies; Diuresis; Female; Furosemide; Humans; Kidney; Lysine; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Retrospective Studies; Urea; Ureter; Urinary Bladder

2019
Simplified Methods for Quantification of
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2019, Volume: 60, Issue:12

    Topics: Aged; Aged, 80 and over; Biological Transport; Humans; Lysine; Male; Middle Aged; Positron-Emission Tomography; Prostatic Neoplasms; Tissue Distribution; Urea

2019
Peripheral ganglia in healthy rats as target structures for the evaluation of PSMA imaging agents.
    BMC cancer, 2019, Jun-26, Volume: 19, Issue:1

    Topics: Animals; Antigens, Surface; Autoradiography; Gallium Isotopes; Gallium Radioisotopes; Ganglia; Ganglia, Spinal; Glutamate Carboxypeptidase II; Lysine; Male; Membrane Glycoproteins; Mice; Mice, SCID; Organ Specificity; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Rats; Rats, Long-Evans; Rats, Wistar; Trigeminal Ganglion; Urea

2019
18F-DCFPyL PET/CT in a Single Large Metastasis With Prostate-Specific Antigen Level of 856 ng/mL.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:10

    Topics: Aged; Glutamate Carboxypeptidase II; Humans; Lysine; Male; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Urea

2019
Concomitant Prostate Carcinoma and Follicular Lymphoma: "Flip-Flop" Appearances on PSMA and FDG PET/CT Scans.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:10

    Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoma, Follicular; Lysine; Male; Neoplasm Metastasis; Neoplasms, Second Primary; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Urea

2019
18F-DCFPyL Uptake in an Incidentally Detected Follicular Lymphoma by PET/CT Performed for Biochemically Recurrent Prostate Cancer.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:2

    Topics: Aged; Biological Transport; Humans; Incidental Findings; Lymphoma, Follicular; Lysine; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Recurrence; Urea

2020
Loss of SUMOylation on ATF3 inhibits proliferation of prostate cancer cells by modulating CCND1/2 activity.
    International journal of molecular sciences, 2013, Apr-16, Volume: 14, Issue:4

    Topics: Activating Transcription Factor 3; Amino Acid Substitution; Androgens; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin D2; Humans; Lysine; Male; Mutagenesis, Site-Directed; Neoplasms, Hormone-Dependent; Prostate; Prostatic Neoplasms; Recombinant Proteins; RNA, Messenger; RNA, Neoplasm; Sumoylation; Transfection

2013
99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen for molecular imaging of prostate cancer.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:8

    Topics: Acetates; Animals; Antigens, Surface; Biological Transport; Cell Line, Tumor; Chelating Agents; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Lysine; Male; Mice; Molecular Imaging; Organotechnetium Compounds; Prostatic Neoplasms; Protease Inhibitors; Radiochemistry; Radionuclide Imaging; Technetium; Urea

2013
ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss.
    Nature medicine, 2013, Volume: 19, Issue:8

    Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Chromatin Immunoprecipitation; Disease Models, Animal; DNA-Binding Proteins; Genes; Histones; Humans; Lysine; Male; Mice; Oncogene Proteins; Phenotype; Principal Component Analysis; Prostate; Prostatic Neoplasms; Proto-Oncogene Proteins c-ets; PTEN Phosphohydrolase; Receptors, Androgen; Signal Transduction; Transcription Factors; Transcriptional Regulator ERG; Transcriptome

2013
Id4 dependent acetylation restores mutant-p53 transcriptional activity.
    Molecular cancer, 2013, Dec-13, Volume: 12

    Topics: Acetylation; Apoptosis; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Differentiation Proteins; Lysine; Male; Mutation; p300-CBP Transcription Factors; Prostatic Neoplasms; Tumor Suppressor Protein p53

2013
A role for WDR5 in integrating threonine 11 phosphorylation to lysine 4 methylation on histone H3 during androgen signaling and in prostate cancer.
    Molecular cell, 2014, May-22, Volume: 54, Issue:4

    Topics: Androgens; Cell Line, Tumor; Cell Proliferation; Chromatin; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; HeLa Cells; Histone-Lysine N-Methyltransferase; Histones; Humans; Intracellular Signaling Peptides and Proteins; Lysine; Male; Methylation; Myeloid-Lymphoid Leukemia Protein; Phosphorylation; Prostatic Neoplasms; Protein Kinase C; Receptors, Androgen; Signal Transduction; Threonine

2014
TRAF6 promotes TGFβ-induced invasion and cell-cycle regulation via Lys63-linked polyubiquitination of Lys178 in TGFβ type I receptor.
    Cell cycle (Georgetown, Tex.), 2015, Volume: 14, Issue:4

    Topics: Cell Cycle; Cell Line, Tumor; Flow Cytometry; Fluorescent Antibody Technique; Humans; Immunoblotting; Immunoprecipitation; Lysine; Male; Microarray Analysis; Neoplasm Invasiveness; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Real-Time Polymerase Chain Reaction; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Statistics, Nonparametric; TNF Receptor-Associated Factor 6; Ubiquitination

2015
Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer.
    Molecular imaging and biology, 2015, Volume: 17, Issue:4

    Topics: Aged; Antigens, Surface; Feasibility Studies; Glutamate Carboxypeptidase II; Humans; Lysine; Male; Middle Aged; Positron-Emission Tomography; Prostate; Prostatic Neoplasms; Radiometry; Tissue Distribution; Urea

2015
Impact of Oxidative Stress Biomarkers and Carboxymethyllysine (an Advanced Glycation End Product) on Prostate Cancer: A Prospective Study.
    Clinical genitourinary cancer, 2015, Volume: 13, Issue:5

    Topics: Aged; Biomarkers; Case-Control Studies; Humans; Lysine; Male; Middle Aged; Oxidative Stress; Prospective Studies; Prostatic Neoplasms; Regression Analysis

2015
Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer.
    Molecular imaging and biology, 2015, Volume: 17, Issue:4

    Topics: Aged; Aged, 80 and over; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Liver; Lysine; Male; Middle Aged; Oligopeptides; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Recurrence; Urea

2015
Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:9

    Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Humans; Iodine Radioisotopes; Kallikreins; Lysine; Male; Molecular Targeted Therapy; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Dosage; Radiopharmaceuticals; Radiotherapy; Treatment Outcome; Urea

2015
Exposure of Human Prostaspheres to Bisphenol A Epigenetically Regulates SNORD Family Noncoding RNAs via Histone Modification.
    Endocrinology, 2015, Volume: 156, Issue:11

    Topics: Benzhydryl Compounds; Cluster Analysis; CpG Islands; DNA Methylation; Dose-Response Relationship, Drug; Epigenesis, Genetic; Epithelial Cells; Estradiol; Estrogens; Estrogens, Non-Steroidal; Histone Code; Histones; Humans; Lysine; Male; Methylation; Phenols; Prostate; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Untranslated; Stem Cells; Transcriptome

2015
Structural changes in histone H2A by methylglyoxal generate highly immunogenic amorphous aggregates with implications in auto-immune response in cancer.
    Glycobiology, 2016, Volume: 26, Issue:2

    Topics: Adolescent; Adult; Animals; Antibodies, Neoplasm; Autoantibodies; Case-Control Studies; Epitopes; Female; Gastrointestinal Neoplasms; Histones; Humans; Lung Neoplasms; Lysine; Male; Middle Aged; Prostatic Neoplasms; Pyruvaldehyde; Rabbits

2016
Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines.
    Biochemistry and cell biology = Biochimie et biologie cellulaire, 2016, Volume: 94, Issue:1

    Topics: Acetylation; Cell Line, Tumor; Chromatin; Chromatin Immunoprecipitation; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Histones; Humans; Isothiocyanates; Lysine; Male; Methyl-CpG-Binding Protein 2; Methylation; Nucleosomes; Phytochemicals; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Processing, Post-Translational; Sulfoxides; Telomerase; Transcription, Genetic

2016
A biomimetic approach to hormone resistant prostate cancer cell isolation using inactivated Sendai virus (HVJ-E).
    Biomaterials science, 2016, Volume: 4, Issue:1

    Topics: Biomimetics; Cell Line, Tumor; Cell Separation; Cell Survival; Humans; Lysine; Male; Oncolytic Virotherapy; Prostatic Neoplasms; Sendai virus

2016
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
    Journal of the National Cancer Institute, 2016, Volume: 108, Issue:2

    Topics: Adult; Aged; BRCA2 Protein; Breast Neoplasms; Codon, Terminator; Female; Genetic Predisposition to Disease; Heterozygote; Humans; Logistic Models; Lysine; Male; Middle Aged; Neoplasm Invasiveness; Odds Ratio; Ovarian Neoplasms; Polymorphism, Single Nucleotide; Prostatic Neoplasms; Risk Assessment; Risk Factors

2016
PSMA-Based Detection of Prostate Cancer Bone Lesions With ¹⁸F-DCFPyL PET/CT: A Sensitive Alternative to (⁹⁹m)Tc-MDP Bone Scan and Na¹⁸F PET/CT?
    Clinical genitourinary cancer, 2016, Volume: 14, Issue:1

    Topics: Antigens, Surface; Bone Neoplasms; Glutamate Carboxypeptidase II; Humans; Lysine; Male; Middle Aged; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sodium Fluoride; Technetium Tc 99m Medronate; Tissue Distribution; Tomography, X-Ray Computed; Urea; Whole Body Imaging

2016
SET8 induces epithelial‑mesenchymal transition and enhances prostate cancer cell metastasis by cooperating with ZEB1.
    Molecular medicine reports, 2016, Volume: 13, Issue:2

    Topics: Cadherins; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Histone-Lysine N-Methyltransferase; Histones; Homeodomain Proteins; Humans; Lysine; Male; Methylation; Neoplasm Metastasis; Prostatic Neoplasms; Protein Binding; Transcription Factors; Transcription, Genetic; Vimentin; Zinc Finger E-box-Binding Homeobox 1

2016
Hypoacetylation, hypomethylation, and dephosphorylation of H2B histones and excessive histone deacetylase activity in DU-145 prostate cancer cells.
    Journal of hematology & oncology, 2016, Jan-12, Volume: 9

    Topics: Acetylation; Amino Acid Sequence; Butyric Acid; Cell Line; Cell Line, Tumor; Chromatography, Liquid; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Lysine; Male; Methylation; Molecular Sequence Data; Phosphorylation; Prostatic Neoplasms; Protein Processing, Post-Translational; Tandem Mass Spectrometry; Threonine

2016
Correlation of PSMA-Targeted
    Clinical genitourinary cancer, 2017, Volume: 15, Issue:1

    Topics: Aged; Antigens, Surface; Carcinoma, Neuroendocrine; Glutamate Carboxypeptidase II; Humans; Lysine; Male; Molecular Imaging; Mutation; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Retinoblastoma Binding Proteins; Tumor Suppressor Protein p53; Ubiquitin-Protein Ligases; Urea

2017
SKP2 loss destabilizes EZH2 by promoting TRAF6-mediated ubiquitination to suppress prostate cancer.
    Oncogene, 2017, Volume: 36, Issue:10

    Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Enhancer of Zeste Homolog 2 Protein; Gene Knockout Techniques; Histones; Humans; Lysine; Male; Mice; Prostate; Prostatic Neoplasms; Protein Stability; PTEN Phosphohydrolase; S-Phase Kinase-Associated Proteins; TNF Receptor-Associated Factor 6; Tumor Suppressor Protein p53; Ubiquitination

2017
ID4 regulates transcriptional activity of wild type and mutant p53 via K373 acetylation.
    Oncotarget, 2017, Jan-10, Volume: 8, Issue:2

    Topics: Acetylation; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Inhibitor of Differentiation Proteins; Lysine; Male; Mutation; Prostatic Neoplasms; Tumor Suppressor Protein p53

2017
Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer.
    Nature, 2017, 02-23, Volume: 542, Issue:7642

    Topics: beta-Transducin Repeat-Containing Proteins; Breast Neoplasms; Cell Line, Tumor; Chromatin Assembly and Disassembly; DNA Helicases; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; Genes, Essential; Glycogen Synthase Kinase 3 beta; Histones; Humans; Lysine; Male; Methylation; Molecular Targeted Therapy; Neoplasms; NF-kappa B; Phosphorylation; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Protein Stability; Proteolysis; PTEN Phosphohydrolase; Tumor Necrosis Factor-alpha; Ubiquitination

2017
Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer.
    Science (New York, N.Y.), 2008, Dec-12, Volume: 322, Issue:5908

    Topics: 3' Untranslated Regions; Algorithms; Breast Neoplasms; Cell Line, Tumor; Disease Progression; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Genome, Human; Histones; Humans; Lysine; Male; Methylation; MicroRNAs; Neoplasm Metastasis; Neoplasms; Polycomb Repressive Complex 2; Promoter Regions, Genetic; Prostatic Neoplasms; RNA, Small Interfering; Stomach Neoplasms; Transcription Factors

2008
SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells.
    Molecular endocrinology (Baltimore, Md.), 2009, Volume: 23, Issue:3

    Topics: Acetylation; Androgens; Animals; Cell Nucleus; Chlorocebus aethiops; COS Cells; Cysteine Endopeptidases; Endopeptidases; Gene Expression Regulation, Neoplastic; Humans; Lysine; Male; Phosphorylation; Prostatic Neoplasms; Protein Conformation; Protein Processing, Post-Translational; Protein Transport; Receptors, Androgen; SUMO-1 Protein; Tumor Cells, Cultured

2009
Genome-wide profiling of histone h3 lysine 4 and lysine 27 trimethylation reveals an epigenetic signature in prostate carcinogenesis.
    PloS one, 2009, Volume: 4, Issue:3

    Topics: Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genome, Human; Histones; Humans; Immunoprecipitation; Lysine; Male; Methylation; MicroRNAs; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms

2009
Suppression of human solid tumor growth in mice by intratumor and systemic inoculation of histidine-rich and pH-dependent host defense-like lytic peptides.
    Cancer research, 2009, Apr-15, Volume: 69, Issue:8

    Topics: Adenocarcinoma; Animals; Carcinoma, Lewis Lung; Cell Growth Processes; Cell Line, Tumor; Histidine; Humans; Hydrogen-Ion Concentration; Lysine; Male; Mice; Mice, Nude; NIH 3T3 Cells; Oligopeptides; Prostatic Neoplasms; Structure-Activity Relationship; Xenograft Model Antitumor Assays

2009
Histone acetyltransferase Hbo1: catalytic activity, cellular abundance, and links to primary cancers.
    Gene, 2009, May-01, Volume: 436, Issue:1-2

    Topics: Acetylation; Binding Sites; Blotting, Western; Breast Neoplasms; Catalysis; Catalytic Domain; Cell Line; Cell Line, Tumor; Electrophoresis, Polyacrylamide Gel; Female; Histone Acetyltransferases; Histones; Humans; Immunohistochemistry; Kidney Neoplasms; Lysine; Male; Neoplasms; Nucleosomes; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Recombinant Proteins; Tissue Array Analysis; Urinary Bladder Neoplasms

2009
Hyperacetylation in prostate cancer induces cell cycle aberrations, chromatin reorganization and altered gene expression profiles.
    Journal of cellular and molecular medicine, 2010, Volume: 14, Issue:6B

    Topics: Acetylation; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chromatin; Dose-Response Relationship, Drug; Flow Cytometry; G1 Phase; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histones; Humans; Hydroxamic Acids; Lysine; Male; Prostatic Neoplasms

2010
The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands.
    Genome research, 2009, Volume: 19, Issue:11

    Topics: Cell Line; Cell Line, Tumor; Chromatin Immunoprecipitation; CpG Islands; DNA Methylation; Female; Genetic Predisposition to Disease; Histones; Humans; Lysine; Male; Methylation; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Binding; RNA Polymerase II; Transcription, Genetic

2009
Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer.
    Cancer research, 2009, Sep-01, Volume: 69, Issue:17

    Topics: Animals; Antigens, Surface; Cell Line, Tumor; Drug Evaluation, Preclinical; Glutamate Carboxypeptidase II; Glutamates; Humans; Iodine Radioisotopes; Lysine; Male; Mice; Mice, Nude; Neoplasm Transplantation; Prostatic Neoplasms; Protein Binding; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Urea

2009
Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4.
    Nature, 2010, Apr-01, Volume: 464, Issue:7289

    Topics: Androgens; Animals; Cell Division; Cell Line, Tumor; Chromatin; Gene Expression Regulation; Gene Knockdown Techniques; Histone Demethylases; Histones; Humans; Lysine; Male; Methylation; Mice; Mice, Nude; Mice, SCID; Phosphorylation; Phosphothreonine; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Kinase C; Protein Kinase C beta; Signal Transduction; Xenograft Model Antitumor Assays

2010
ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer.
    PloS one, 2010, May-10, Volume: 5, Issue:5

    Topics: Aged; Anoikis; Cell Movement; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Silencing; Histones; Homeodomain Proteins; Humans; Lysine; Male; Methylation; Middle Aged; Models, Genetic; Polycomb Repressive Complex 2; Prostatic Neoplasms; Proto-Oncogene Proteins c-ets; Trans-Activators; Transcription Factors; Transcription, Genetic; Transcriptional Regulator ERG; Tumor Suppressor Proteins; Up-Regulation

2010
Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a.
    Molecular cell, 2010, Jun-11, Volume: 38, Issue:5

    Topics: Animals; Cell Line, Tumor; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p15; Cyclin-Dependent Kinase Inhibitor p16; Gene Silencing; Histones; Humans; Lysine; Male; Methylation; Models, Molecular; Molecular Sequence Data; Multigene Family; Nuclear Magnetic Resonance, Biomolecular; Polycomb Repressive Complex 1; Polycomb-Group Proteins; Prostatic Neoplasms; Protein Structure, Tertiary; Repressor Proteins; RNA, Untranslated; Transcription, Genetic

2010
Regulation of the androgen receptor by SET9-mediated methylation.
    Nucleic acids research, 2011, Volume: 39, Issue:4

    Topics: Active Transport, Cell Nucleus; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Male; Methylation; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Transcriptional Activation

2011
Novel histone deacetylase inhibitor CG200745 induces clonogenic cell death by modulating acetylation of p53 in cancer cells.
    Investigational new drugs, 2012, Volume: 30, Issue:2

    Topics: Acetylation; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Colorectal Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Genes, Reporter; Half-Life; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Lysine; Male; Mutation; Naphthalenes; Prostatic Neoplasms; Protein Stability; Proto-Oncogene Proteins c-mdm2; Time Factors; Transcriptional Activation; Transfection; Tumor Stem Cell Assay; Tumor Suppressor Protein p53

2012
Low-dose valproic acid enhances radiosensitivity of prostate cancer through acetylated p53-dependent modulation of mitochondrial membrane potential and apoptosis.
    Molecular cancer research : MCR, 2011, Volume: 9, Issue:4

    Topics: Acetylation; Apoptosis; Cell Line, Tumor; Histone Deacetylase Inhibitors; Humans; Lysine; Male; Membrane Potential, Mitochondrial; Prostatic Neoplasms; Radiation Tolerance; Radiation-Sensitizing Agents; Tumor Suppressor Protein p53; Valproic Acid

2011
Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth.
    Molecular cell, 2011, Jun-24, Volume: 42, Issue:6

    Topics: Acetylation; Animals; Autophagy; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Activation; Glucose; Humans; Isoenzymes; Lysine; Lysosomes; Male; Mice; Mice, Nude; Molecular Chaperones; Mutation; p300-CBP Transcription Factors; Prostatic Neoplasms; Pyruvate Kinase; Structure-Activity Relationship; Xenograft Model Antitumor Assays

2011
PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties.
    Nuclear medicine and biology, 2011, Volume: 38, Issue:7

    Topics: Amino Acid Sequence; Animals; Bombesin; Cell Line, Tumor; Cell Transformation, Neoplastic; Humans; Lysine; Male; Mice; Molecular Weight; Octanols; Organotechnetium Compounds; Phosphates; Polyethylene Glycols; Prostatic Neoplasms; Protein Transport; Receptors, Bombesin; Structure-Activity Relationship

2011
2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Dec-15, Volume: 17, Issue:24

    Topics: Animals; Antigens, Surface; Cell Line, Tumor; Fluorine Radioisotopes; Glutamate Carboxypeptidase II; Humans; Lysine; Male; Mice; Mice, Inbred NOD; Mice, SCID; Molecular Structure; Neoplasms, Experimental; Positron-Emission Tomography; Prostatic Neoplasms; Radiometry; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Transplantation, Heterologous; Urea

2011
A cell-based high-throughput screening assay to measure cellular histone h3 lys27 trimethylation with a modified dissociation-enhanced lanthanide fluorescent immunoassay.
    Journal of biomolecular screening, 2012, Volume: 17, Issue:1

    Topics: Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluorescent Antibody Technique; High-Throughput Screening Assays; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Lanthanoid Series Elements; Lysine; Male; Methylation; Prostatic Neoplasms

2012
Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2012, Apr-11, Volume: 45, Issue:5

    Topics: Animals; Cations; Down-Regulation; Endosomes; Gene Knockdown Techniques; Gene Silencing; Genetic Vectors; Humans; Hydrogen-Ion Concentration; Hydrolysis; Lysine; Lysosomes; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Particle Size; Polyamines; Polyelectrolytes; Polyethylene Glycols; Prostatic Neoplasms; RNA, Messenger; RNA, Small Interfering; Surface-Active Agents; Vascular Endothelial Growth Factor A

2012
Global levels of H3K27me3 track with differentiation in vivo and are deregulated by MYC in prostate cancer.
    The American journal of pathology, 2012, Volume: 181, Issue:2

    Topics: Animals; Cell Compartmentation; Cell Differentiation; Cell Line, Tumor; Enhancer of Zeste Homolog 2 Protein; Histones; Humans; Immunohistochemistry; Inflammation; Lysine; Male; Methylation; Mice; Organ Specificity; Polycomb Repressive Complex 2; Prostate; Prostatectomy; Prostatic Neoplasms; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-myc; RNA, Small Interfering; Stem Cells; Tissue Array Analysis

2012
Acetylation-dependent regulation of Skp2 function.
    Cell, 2012, Jul-06, Volume: 150, Issue:1

    Topics: Acetylation; Amino Acid Sequence; Animals; Breast Neoplasms; Cadherins; Casein Kinase I; Cell Line, Tumor; Cell Movement; Cytoplasm; Disease Models, Animal; Humans; Lysine; Male; Mice; Molecular Sequence Data; p300-CBP Transcription Factors; Prostatic Neoplasms; Protein Processing, Post-Translational; Protein Sorting Signals; S-Phase Kinase-Associated Proteins; Sequence Alignment; Ubiquitination

2012
Inflammation-mediated abrogation of androgen signaling: an in vitro model of prostate cell inflammation.
    Molecular carcinogenesis, 2014, Volume: 53, Issue:2

    Topics: Acetylcysteine; Androgens; Antioxidants; Apoptosis; Cell Differentiation; Cell Line, Tumor; Down-Regulation; Glutathione Peroxidase; Homeodomain Proteins; Humans; I-kappa B Proteins; Inflammation; Inflammation Mediators; Interleukin-1beta; Interleukin-6; Kallikreins; Lysine; Macrophages; Male; Matrix Metalloproteinase 9; NF-kappa B; Phosphorylation; Prostate-Specific Antigen; Prostatic Neoplasms; Prostatitis; Proto-Oncogene Proteins c-mdm2; Reactive Oxygen Species; Receptors, Androgen; Signal Transduction; Transcription Factors; Transcriptional Activation; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53; U937 Cells; Up-Regulation

2014
Agglomerates of aberrant DNA methylation are associated with toxicant-induced malignant transformation.
    Epigenetics, 2012, Volume: 7, Issue:11

    Topics: Animals; Arsenic; Cadherins; Carcinoma; Cell Line, Tumor; Cell Transformation, Neoplastic; DNA Methylation; DNA, Neoplasm; Epigenesis, Genetic; Female; Genes, Homeobox; Histones; Humans; Lysine; Male; Mice; Mice, Nude; Multigene Family; Neoplasm Transplantation; Prostatic Neoplasms; Protein Processing, Post-Translational

2012
Stabilization of the prostate-specific tumor suppressor NKX3.1 by the oncogenic protein kinase Pim-1 in prostate cancer cells.
    Journal of cellular biochemistry, 2013, Volume: 114, Issue:5

    Topics: Azepines; Cell Line, Tumor; DNA Mutational Analysis; Half-Life; Homeodomain Proteins; Humans; Indoles; Lysine; Male; Models, Biological; Mutant Proteins; Organ Specificity; Phosphorylation; Prostate; Prostatic Neoplasms; Protein Biosynthesis; Protein Kinase Inhibitors; Protein Stability; Protein Transport; Proto-Oncogene Proteins c-pim-1; Substrate Specificity; Transcription Factors; Tumor Suppressor Proteins

2013
Synthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigen.
    Bioconjugate chemistry, 2012, Dec-19, Volume: 23, Issue:12

    Topics: Animals; Carboxylic Acids; Disease Models, Animal; Fluorescent Dyes; Glutamate Carboxypeptidase II; Humans; Kinetics; Lysine; Male; Membrane Glycoproteins; Mice; Mice, Nude; Molecular Imaging; Molecular Weight; Polyethylene Glycols; Prostate; Prostatic Neoplasms; Spectroscopy, Near-Infrared

2012
Pathologic characterization of human prostate tissue with proton MR spectroscopy.
    Radiology, 2003, Volume: 228, Issue:1

    Topics: Adenocarcinoma; Biomarkers, Tumor; Choline; Citrates; Creatinine; Diagnosis, Differential; Humans; Lipids; Lysine; Magnetic Resonance Spectroscopy; Male; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Sensitivity and Specificity

2003
New lytic peptides based on the D,L-amphipathic helix motif preferentially kill tumor cells compared to normal cells.
    Biochemistry, 2003, Aug-12, Volume: 42, Issue:31

    Topics: Anti-Infective Agents; Antimicrobial Cationic Peptides; Cell Death; Cell Membrane; Fluoresceins; Hemolysis; Humans; Leucine; Lysine; Male; Melanoma, Experimental; Membrane Lipids; Microscopy, Confocal; Mitomycin; Phosphatidylserines; Prostatic Neoplasms; Protein Conformation; Rhodamines; Skin; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Stereoisomerism; Structure-Activity Relationship; Surface Plasmon Resonance; Tumor Cells, Cultured

2003
EXPERIMENTAL AND CLINICAL EVALUATION OF ARGINASE INHIBITOR IN CHRONIC URINARY OBSTRUCTION.
    The Journal of the International College of Surgeons, 1965, Volume: 43

    Topics: Arginase; Biomedical Research; Dogs; Enzyme Inhibitors; Humans; Lysine; Male; Neoplasms; Preoperative Care; Prostatic Hyperplasia; Prostatic Neoplasms; Research; Uremia; Urethral Stricture; Urinary Bladder Neck Obstruction; Urologic Diseases

1965
The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity.
    The Journal of biological chemistry, 2004, Jul-09, Volume: 279, Issue:28

    Topics: Acetylation; Animals; Cell Line, Tumor; Cyclic AMP; Enzyme Inhibitors; Gene Expression Regulation; Genes, Reporter; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; JNK Mitogen-Activated Protein Kinases; Ligands; Lysine; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Phosphates; Point Mutation; Prostatic Neoplasms; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, Androgen; Transcription, Genetic

2004
Inhibition of tumor growth and elimination of multiple metastases in human prostate and breast xenografts by systemic inoculation of a host defense-like lytic peptide.
    Cancer research, 2006, May-15, Volume: 66, Issue:10

    Topics: Adenocarcinoma; Amino Acid Sequence; Animals; Breast Neoplasms; Cell Growth Processes; Cell Line, Tumor; Female; Humans; Leucine; Lung Neoplasms; Lysine; Male; Membrane Potentials; Mice; Mice, SCID; Neoplasm Metastasis; Peptides; Phosphatidylserines; Prostate-Specific Antigen; Prostatic Neoplasms; Xenograft Model Antitumor Assays

2006
Acetylation and phosphorylation of high-mobility group A1 proteins in PC-3 human tumor cells.
    Biochemistry, 2006, Jun-13, Volume: 45, Issue:23

    Topics: Acetylation; Amino Acid Sequence; Cell Line, Tumor; High Mobility Group Proteins; Humans; Lysine; Male; Molecular Sequence Data; Phosphorylation; Prostatic Neoplasms; Sequence Homology, Amino Acid; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2006
Boc-lysinated-betulonic acid: a potent, anti-prostate cancer agent.
    Bioorganic & medicinal chemistry, 2006, Sep-15, Volume: 14, Issue:18

    Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Hydrophobic and Hydrophilic Interactions; Immunohistochemistry; In Vitro Techniques; Lysine; Male; Mice; Mice, Nude; Mitosis; Molecular Conformation; Oleanolic Acid; Prostatic Neoplasms; Solubility; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2006
Hormonal control of androgen receptor function through SIRT1.
    Molecular and cellular biology, 2006, Volume: 26, Issue:21

    Topics: Acetylation; Amino Acid Sequence; Animals; Cell Cycle Proteins; Cell Line; Cell Proliferation; Dihydrotestosterone; Gene Expression Regulation; Genes, Reporter; Histone Acetyltransferases; Humans; Lysine; Male; Models, Molecular; Molecular Sequence Data; p300-CBP Transcription Factors; Peptides; Prostatic Neoplasms; Receptors, Androgen; Signal Transduction; Sirtuin 1; Sirtuins; Transcription Factors; Transcription, Genetic

2006
Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk: an explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors.
    European urology, 2007, Volume: 52, Issue:4

    Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Amino Acid Substitution; Chemoprevention; Cholestenone 5 alpha-Reductase; Enzyme Inhibitors; Genetic Variation; Genotype; Humans; Lysine; Male; Prostatic Neoplasms; Treatment Failure; Valine

2007
Anti-tumor effect of ascorbic acid, lysine, proline, arginine, and epigallocatechin gallate on prostate cancer cell lines PC-3, LNCaP, and DU145.
    Research communications in molecular pathology and pharmacology, 2004, Volume: 115-116

    Topics: Antioxidants; Arginine; Ascorbic Acid; Catechin; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Collagen; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Formazans; Humans; Laminin; Lysine; Male; Matrix Metalloproteinases; Neoplasm Invasiveness; Proline; Prostatic Neoplasms; Proteoglycans; Tetrazolium Salts

2004
JMJD3 is a histone H3K27 demethylase.
    Cell research, 2007, Volume: 17, Issue:10

    Topics: Binding Sites; Blotting, Western; Databases, Factual; DNA-Binding Proteins; Glutathione Transferase; HeLa Cells; Histones; Humans; Immunohistochemistry; Jumonji Domain-Containing Histone Demethylases; Lysine; Male; Methylation; Mutation; Neoplasm Metastasis; Oxidoreductases, N-Demethylating; Prostatic Neoplasms; Recombinant Fusion Proteins; Transfection

2007
JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-04, Volume: 104, Issue:49

    Topics: Cell Line, Tumor; Computational Biology; Dioxygenases; DNA-Binding Proteins; Gene Expression; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Lysine; Male; Methylation; Nuclear Proteins; Phylogeny; Prostatic Neoplasms; Protein Structure, Tertiary; Repressor Proteins; Up-Regulation

2007
SUMOylation of pontin chromatin-remodeling complex reveals a signal integration code in prostate cancer cells.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-26, Volume: 104, Issue:52

    Topics: ATPases Associated with Diverse Cellular Activities; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Chromatin; DNA Helicases; Humans; Hydroxytestosterones; Lysine; Male; Models, Biological; Prostatic Neoplasms; Signal Transduction; Small Ubiquitin-Related Modifier Proteins; SUMO-1 Protein; Transcription, Genetic; Ubiquitin-Conjugating Enzymes

2007
Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation.
    Nature genetics, 2008, Volume: 40, Issue:6

    Topics: Acetylation; Alkaline Phosphatase; Biomarkers, Tumor; Breast Neoplasms; Cells, Cultured; Chromatin Immunoprecipitation; Colony-Forming Units Assay; CpG Islands; DNA Methylation; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Female; Gene Silencing; Histones; Humans; Lung Neoplasms; Lysine; Male; Microarray Analysis; Microfilament Proteins; Phosphatidylinositol 3-Kinases; Polycomb Repressive Complex 2; Promoter Regions, Genetic; Prostate; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factors

2008
Novel lysine-spermine conjugate inhibits polyamine transport and inhibits cell growth when given with DFMO.
    Experimental cell research, 2000, Nov-25, Volume: 261, Issue:1

    Topics: Animals; Antineoplastic Agents; Biological Transport; Breast Neoplasms; Cell Division; Eflornithine; Female; Humans; Indicators and Reagents; Kinetics; Lysine; Male; Melanoma; Mice; Mice, Nude; Molecular Structure; Polyamines; Prostatic Neoplasms; Spermidine; Spermine; Tumor Cells, Cultured; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays

2000
A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth.
    The Journal of biological chemistry, 2002, Feb-15, Volume: 277, Issue:7

    Topics: Blotting, Western; Carrier Proteins; Down-Regulation; Genes, Dominant; Genes, Reporter; Humans; Intracellular Signaling Peptides and Proteins; Ligands; Lysine; Male; Models, Biological; Mutation; Plasmids; Point Mutation; Prostatic Neoplasms; Protein Binding; Protein Structure, Tertiary; Time Factors; Transcription, Genetic; Transcriptional Activation; Transfection; Tumor Cells, Cultured; Two-Hybrid System Techniques

2002
Occurrence of L-lysine dehydrogenase (LyDH) in human serum in normal and some pathological states.
    Helvetica medica acta, 1967, Volume: 34, Issue:1

    Topics: Adolescent; Adult; Amino Acid Oxidoreductases; Breast Neoplasms; Female; Heart Diseases; Heart Failure; Humans; Kidney Neoplasms; Leukemia, Lymphoid; Lung Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Lysine; Male; Middle Aged; Multiple Myeloma; Myocardial Infarction; Neoplasms; Prostatic Neoplasms; Urogenital Neoplasms

1967